Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway
Overexpressed survivin is associated with worse survival of several types of human tumors. In this study, the antitumor activity of shikonin in non-small-cell lung cancer (NSCLC) by regulating survivin pathway was investigated. Results showed that shikonin inhibited the NSCLC H1299 cell proliferatio...
Guardado en:
Autores principales: | Haini Wang, Junli Zuo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/00a40cfbebe54cb693d63a9ec4b961c3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway
por: Suhong Zhang, et al.
Publicado: (2021) -
Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes
por: Kathryn Davidson, et al.
Publicado: (2021) -
USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1
por: Jinghua Pan, et al.
Publicado: (2021) -
Interplay between ADP-ribosyltransferases and essential cell signaling pathways controls cellular responses
por: Flurina Boehi, et al.
Publicado: (2021) -
ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway
por: Yun Lin, et al.
Publicado: (2021)